NCT05882214View on ClinicalTrials.gov

Metabolic Changes Induced by NMN in Healthy Subjects With Acute Binge Drink

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

February 18, 2025

Study Completion Date

April 6, 2025

Conditions
Binge DrinkingLiver InjuryNutritional SupplementationHepatic Steatosis
Interventions
DIETARY_SUPPLEMENT

β-nicotinamide Mononucleotide

After an 8-hour overnight fast, the participants ingested β-nicotinamide Mononucleotide capsules with a single morning dose of 1000mg. The purity of β-nicotinamide Mononucleotide capsules was no less than 97% according to high-performance liquid chromatography analysis.

DIETARY_SUPPLEMENT

Maltodextrin

After an 8-hour overnight fast, the participants ingested maltodextrin capsules with a single morning dose of 1000mg.

Trial Locations (1)

310053

Zhejiang Chinese Medical University, Hangzhou

All Listed Sponsors
lead

Zhejiang Chinese Medical University

OTHER_GOV

NCT05882214 - Metabolic Changes Induced by NMN in Healthy Subjects With Acute Binge Drink | Biotech Hunter | Biotech Hunter